Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al

Documents similaires

• Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al
  par: Teng‐Fei Li, et autres
  Publié: (2025)
• Efficacy and safety of SGLT2 inhibitors in preventing cardiovascular and renal events in patients with systemic lupus erythematosus and type 2 diabetes: comment on the article by Ma et al
  par: Zichang Liu, et autres
  Publié: (2025)
• Target trial emulation and cardiovascular safety inference in gout: comment on the article by Yokose et al.
  par: Jian Huang
  Publié: (2026)
• Methodological considerations for “Proinflammatory dietary pattern and the risk of female gout”: comment on the article by Rai et al
  par: Fusen Chen, et autres
  Publié: (2025)
• Determinants of achieving serum urate goal with treat‐to‐target urate‐lowering therapy in gout: comment on the article by Helget et al
  par: Daniel Small
  Publié: (2024)